|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
11 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses: | ||||
| General and administrative expenses | ||||
| Research and development expenses | ||||
| Depreciation expense | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income | ||||
| Interest and dividend income | ||||
| Interest expense | ||||
| Interest expense, amortization of debt discount | ||||
| Change in fair value of derivative liabilities | ||||
| Loss on extinguishment of debt | ||||
| Total other income | ||||
| Net loss and comprehensive loss | ||||
| Net loss per common share, basic (in Dollars per share) | ||||
| Net loss per common share, Diluted (in Dollars per share) | ||||
| Weighted average number of common shares used in computing net loss per common share, basic (in Shares) | ||||
| Weighted average number of common shares used in computing net loss per common share, Diluted (in Shares) | ||||
Loading...